Structures by: Kamali N.

Total: 56

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0785(2)Å   b=11.5265(3)Å   c=22.8581(6)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0907(3)Å   b=11.5779(4)Å   c=22.8104(7)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1349(3)Å   b=11.6868(4)Å   c=22.8660(8)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0963(2)Å   b=11.5574(3)Å   c=22.8612(7)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1445(3)Å   b=11.7130(3)Å   c=22.8862(5)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1415(4)Å   b=11.7002(4)Å   c=22.8837(6)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1357(3)Å   b=11.6782(3)Å   c=22.8834(6)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1405(3)Å   b=11.6923(2)Å   c=22.8838(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1280(3)Å   b=11.6579(3)Å   c=22.8759(5)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1311(3)Å   b=11.6667(2)Å   c=22.8800(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1237(2)Å   b=11.6442(2)Å   c=22.8738(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1200(3)Å   b=11.6339(3)Å   c=22.8697(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1158(2)Å   b=11.6222(2)Å   c=22.8715(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1066(2)Å   b=11.5983(2)Å   c=22.8627(3)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1070(3)Å   b=11.5902(3)Å   c=22.8593(6)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1064(3)Å   b=11.5845(3)Å   c=22.8569(6)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1048(3)Å   b=11.5802(3)Å   c=22.8576(6)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0992(4)Å   b=11.5635(3)Å   c=22.8525(6)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0972(2)Å   b=11.5751(2)Å   c=22.8531(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0881(3)Å   b=11.5538(2)Å   c=22.8478(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0823(3)Å   b=11.5422(2)Å   c=22.8439(3)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1228(4)Å   b=11.6522(6)Å   c=22.8488(10)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1074(3)Å   b=11.6193(5)Å   c=22.8456(9)Å

α=90°   β=90°   γ=90°

C11H12N4O2S

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.5040(2)Å   b=8.21620(10)Å   c=21.9984(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0885(6)Å   b=11.5482(7)Å   c=22.7898(12)Å

α=90°   β=90°   γ=90°

C11H12N4O2S

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4973(2)Å   b=8.21180(10)Å   c=21.9658(3)Å

α=90°   β=90°   γ=90°

C11H12N4O2S

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.5008(2)Å   b=8.21410(10)Å   c=21.9821(4)Å

α=90°   β=90°   γ=90°

C11H12N4O2S

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.49500(10)Å   b=8.20940(10)Å   c=21.9489(3)Å

α=90°   β=90°   γ=90°

C11H12N4O2S

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.49140(10)Å   b=8.20690(10)Å   c=21.9332(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48840(10)Å   b=8.20480(10)Å   c=21.9167(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48520(10)Å   b=8.20200(10)Å   c=21.9002(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48140(10)Å   b=8.19930(10)Å   c=21.8844(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47950(10)Å   b=8.19740(10)Å   c=21.8693(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4763(2)Å   b=8.19460(10)Å   c=21.8522(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47010(10)Å   b=8.18890(10)Å   c=21.8216(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47340(10)Å   b=8.19210(10)Å   c=21.8397(3)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.46660(10)Å   b=8.18680(10)Å   c=21.8103(2)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.45970(10)Å   b=8.18020(10)Å   c=21.7812(2)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4902(9)Å   b=8.2249(6)Å   c=22.0106(14)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.45880(10)Å   b=8.18000(10)Å   c=21.7664(2)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4899(5)Å   b=8.2086(4)Å   c=21.9106(9)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4829(6)Å   b=8.1938(3)Å   c=21.8441(9)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4687(6)Å   b=8.1829(9)Å   c=21.8084(4)Å

α=90°   β=90°   γ=90°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4393(7)Å   b=8.1764(4)Å   c=21.7395(13)Å

α=90.00°   β=90.00°   γ=90.00°

Sulfamerazine

C11H12N4O2S

Anuradha R. PallipurathJonathan M. SkeltonMark R. WarrenNaghmeh KamaliPatrick McArdleAndrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.46380(10)Å   b=8.18350(10)Å   c=21.7953(2)Å

α=90°   β=90°   γ=90°

C14H15N3O2

C14H15N3O2

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=19.367(3)Å   b=7.1978(8)Å   c=19.4919(16)Å

α=90.00°   β=104.881(11)°   γ=90.00°

C16.5H18N3O6

C16.5H18N3O6

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=11.4553(7)Å   b=11.5940(8)Å   c=14.6223(10)Å

α=68.150(6)°   β=76.810(6)°   γ=74.391(6)°

C16H17N5O2S2

C16H17N5O2S2

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=13.9493(9)Å   b=8.3273(4)Å   c=16.9440(9)Å

α=90.00°   β=113.288(7)°   γ=90.00°

C21H28N4O4

C21H28N4O4

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=5.6600(4)Å   b=18.8049(16)Å   c=19.4650(13)Å

α=90.00°   β=90.00°   γ=90.00°

C11H12N2O4

C11H12N2O4

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=8.8197(6)Å   b=21.1800(12)Å   c=12.3153(10)Å

α=90.00°   β=93.492(7)°   γ=90.00°

C13H13N3O2

C13H13N3O2

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=9.5379(12)Å   b=5.7387(7)Å   c=12.5211(18)Å

α=90.00°   β=109.146(15)°   γ=90.00°

C14H14N2O3

C14H14N2O3

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=7.3446(4)Å   b=16.3851(10)Å   c=11.1975(7)Å

α=90.00°   β=105.157(6)°   γ=90.00°

C14H13N3O3S

C14H13N3O3S

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=10.9623(8)Å   b=5.8715(3)Å   c=12.0212(9)Å

α=90.00°   β=116.754(9)°   γ=90.00°

C10H12N2O4

C10H12N2O4

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=5.5336(5)Å   b=8.9229(9)Å   c=10.9447(11)Å

α=87.095(8)°   β=89.016(8)°   γ=75.137(8)°

C18H20N6O2S

C18H20N6O2S

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=14.0370(8)Å   b=16.2988(6)Å   c=16.6980(7)Å

α=90.00°   β=90.00°   γ=90.00°

C10H12N5O3.5

C10H12N5O3.5

Kamali, NaghmehAljohani, MarwahMcArdle, PatrickErxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=12.1599(15)Å   b=7.1495(11)Å   c=13.5183(14)Å

α=90.00°   β=90.035(10)°   γ=90.00°